InvestorsHub Logo
Followers 2
Posts 118
Boards Moderated 0
Alias Born 05/31/2011

Re: Kmadd post# 30804

Wednesday, 02/10/2021 8:32:05 AM

Wednesday, February 10, 2021 8:32:05 AM

Post# of 34624
I believe these are the same

T-Cell Therapy for Lymphoma Using Nonengineered Multiantigen-Targeted T Cells Is Safe and Produces Durable Clinical Effects
https://ascopubs.org/doi/full/10.1200/JCO.20.02224

For what ever reason there has been no press release. This is very very positive news.... if this was a different company, we probably would have been well north of $10 by now in anticipation of the news, then way up from there to $20’s... but very little following here.

TACTAL – Leukemia: NCT01333046
https://clinicaltrials.gov/ct2/show/NCT01333046?term=multitaa&rank=4

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News